Psychiatry · Florence, AL
NPI
1356306559
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
5
Medicare group memberships
Hospitals
1
Hospital affiliations
1116 Bradshaw Dr
Florence, AL, 35630
Phone (256) 767-4805
Groups this clinician bills Medicare through
Medicare paid, 2024
$31K
507 services
Medicare patients, 2024
151
Average age 58
Drug cost, 2024
$1.4M
11,360 prescriptions
Company payments, 2025
$1,689
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David U Anakwenze was code 99214 (office e&m - established), 354 times for 107 patients. In total David U Anakwenze billed 507 services in 14 codes, and Medicare paid $31K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 354 | 107 | $74.31 | $26K |
| 99232 Hospital E&M - Subsequent | Facility | 54 | 35 | $57.44 | $3,102 |
| 99213 Office E&M - Established | Office | 43 | 43 | $5.62 | $241 |
| Q3014 Telehealth originating site facility fee | Office | 34 | 34 | $1.37 | $46.73 |
By year: 2022 $46K for 8,102 services; 2023 $32K for 2,642 services; 2024 $31K for 507 services.
Medicare prescription drug claims, 2024
In 2024, the drug David U Anakwenze prescribed most often to Medicare patients was Quetiapine Fumarate, with 643 prescriptions and refills. In total David U Anakwenze wrote 11,360 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Quetiapine Fumarate Generic | 643 | 796 | 76 | $7,175 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 586 | 591 | 54 | $14K |
| Divalproex Sodium Er Divalproex Sodium | 535 | 679 | 67 | $21K |
| Buspirone Hcl Generic | 440 | 550 | 64 | $4,471 |
| Trazodone Hcl Generic | 423 | 571 | 63 | $2,763 |
| Fluoxetine Hcl Generic | 411 | 543 | 55 | $2,997 |
| Clonazepam Generic | 405 | 411 | 68 | $1,172 |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | 364 | 368 | 45 | $23K |
| Zolpidem Tartrate Generic | 353 | 413 | 48 | $2,160 |
| Benztropine Mesylate Generic | 331 | 382 | 33 | $2,899 |
| Hydroxyzine Hcl Generic | 310 | 374 | 58 | $4,211 |
| Lamotrigine Generic | 298 | 397 | 39 | $2,764 |
| Sertraline Hcl Generic | 294 | 383 | 43 | $1,637 |
| Bupropion Xl Bupropion Hcl | 276 | 376 | 40 | $4,798 |
| Oxcarbazepine Generic | 228 | 294 | 29 | $5,933 |
Brand drugs: 750 claims; generic drugs: 10,610 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David U Anakwenze $1,689 ($1,689 in general payments such as food, travel and fees) from 12 companies. The largest payer was Alkermes, Inc. with $555.
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. ALKS | 22 | $555 |
| Vanda Pharmaceuticals Inc. VNDA | 8 | $219 |
| Teva Pharmaceuticals USA, Inc. TEVA | 5 | $209 |
| Neurocrine BioSciences, Inc. NBIX | 8 | $182 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $150 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 7 | $146 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $88.64 |
| Almatica Pharma LLC | 2 | $44.52 |
| Axsome Therapeutics, Inc. AXSM | 2 | $35.69 |
| Janssen Pharmaceuticals, Inc JNJ | 2 | $30.98 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.